腫瘍段階による腎臓細胞がん患者の心血管疾患とがん死亡率の縦断的なパターン
Zhengyi Deng1, Minji Jung1, Mingyi Li2
1Department of Urology, Stanford School of Medicine, Stanford, California, USA.
JACC. CardioOncology
|August 21, 2025
まとめ
心血管疾患 (CVD) による死亡率は,特に早期がん患者では,腎臓細胞癌 (RCC) による死亡率を上回ります. RCC患者の生存率を向上させるには,両疾患の対応が不可欠です.
科学分野:
- 腫瘍学
- 心臓病科
- 流行病学
背景:
- 心血管疾患 (CVD) は,腎臓細胞癌 (RCC) の患者の非癌死亡の主な原因です.
- CVDとRCCの死亡率の相互作用を理解することは,患者のアウトカムを改善するために非常に重要です.
研究 の 目的:
- 診断後のCVDとRCCの死亡率の時間的な傾向を分析する.
- 異なるRCC腫瘍段階における死亡率の時間依存の危険因子を特定する.
主な方法:
- 116,836人の成人RCC患者に対して,サーベイランス,疫学,および最終結果 (SEER) データベース (2004-2020) を利用した.
- 死亡率をモデル化するためのポアソン回帰とリスク因子分析のためのファイナグレイの競合リスクモデルを使用した.
- RCC死亡率を超えたクロスオーバー時間を決定し,腫瘍段階によって層分化した.
主要な成果:
- 総合的に見ると,CVDによる死亡は,RCCによる死亡を13.7年に上回っている.
- ステージIのRCCでは,このクロスオーバーは2. 8年でかなり早く発生しました.
- 75歳以上の患者と非ヒスパニック系黒人の患者では,すべての段階でクロスオーバーが認められ,社会統計学的および臨床的要因が死亡率に影響した.
結論:
- ステージIのRCC患者は,CVDの死亡率がRCCの死亡率に優れているという明確な傾向を示しています.
- 癌と心臓血管の健康の両方に対処する統合された管理戦略は,生存率を高めるために不可欠です.
- 腫瘍の段階と患者の特徴に合わせて個別化された生存ケアプランが推奨されます.
さらに関連する動画
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
13.7K
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
376
関連する概念動画
01:21Cancer Survival Analysis
453
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
453
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
02:20Longitudinal Research
12.5K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.5K
02:53Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K